M. Kawaguchi

An Exploratory Study on the Anti-inflammatory Effects of Fucoidan in Relation to Quality of Life in Advanced Cancer Patients

S. Narumiya, K. Teruya, S. Shirahata, 2017, Integrative cancer therapies.

A prospective and comparative cohort study on efficacy and drug resistance during long‐term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis

Y. Shiratori, A. Takaki, Kazuhide Yamamoto, 2008, Journal of gastroenterology and hepatology.

Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B

K. Tanikawa, N. Hayashi, M. Sata, 2009, Hepatology international.

Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2

Y. Shiratori, Noriaki Aoki, Hironori Tanaka, 2011, Scandinavian journal of gastroenterology.

Diffuse Intestinal Ganglioneuromatosis Showing Multiple Large Bowel Ulcers in a Patient with Neurofibromatosis Type 1

M. Iwamuro, F. Otsuka, H. Okada, 2017, Internal medicine.

Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

Y. Shiratori, Y. Iwasaki, K. Takaguchi, 2004, Liver international : official journal of the International Association for the Study of the Liver.

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

Y. Shiratori, Y. Iwasaki, K. Takaguchi, 2006, Hepatology.

Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy.

H. Hagihara, A. Takaki, Y. Takeuchi, 2018, Acta medica Okayama.

Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.

M. Okita, T. Sasagawa, Y. Ota, 2003, Nutrition.

A case of acute hepatitis E virus infection with clinical features indistinguishable from drug-induced liver injury

M. Iwamuro, Kazuhide Yamamoto, Kazuaki Takahashi, 2005 .

Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study.

N. Tsukada, Y. Imari, M. Tatemichi, 2010, Oncology letters.